A series of patients with hospital-acquired diabetic ketoacidosis (HADKA): a descriptive analysis
- PMID: 36241364
- PMCID: PMC9761435
- DOI: 10.7861/clinmed.2022-0300
A series of patients with hospital-acquired diabetic ketoacidosis (HADKA): a descriptive analysis
Abstract
Background: Hospital-acquired diabetic ketoacidosis (HADKA) can complicate hospital admission in people with type 1 diabetes (T1D) and type 2 diabetes (T2D). We aimed to determine the characteristics of such patients and the reasons for HADKA.
Methods: A retrospective analysis of patients referred to diabetes services with HADKA at Morriston Hospital between January 2016 and January 2022 was undertaken. Patients that were included were admitted without diabetic ketoacidosis (DKA), were aged 18 years and over, and who subsequently developed DKA in hospital.
Results: Twenty-five patients were included with a mean age of 65.2 years; nine (32.0%) were men, 13 (52.0%) had T1D and 12 (48.0%) had T2D. Patients had a mean pre-admission glycated haemoglobin of 84.7 mmol/mol, and 17 (68.0%) were insulin-treated. Most were admitted under medicine (n=14; 56.0%) and the remainder under surgery (n=11; 44.0%). More common reasons for HADKA were erroneous insulin administration (n=9; 36.0%), infection (n=7; 28.0%) and surgery (n=5; 20.0%).Five (20.0%) patients required intensive care admission, and the mean length of hospital stay was 42.6 days (range 2-173). Three (12.0%) patients died during the hospital admission.
Conclusion: HADKA was identified in a significant number of patients at our hospital and was associated with significant mortality. Earlier recognition of ketonaemia and associated medication use may prevent HADKA and improve outcomes.
Keywords: complications; diabetic ketoacidosis; inpatient.
© Royal College of Physicians 2022. All rights reserved.
Figures
Similar articles
-
Clinical and biochemical determinants of length of stay, readmission and recurrence in patients admitted with diabetic ketoacidosis.Ann Med. 2023 Dec;55(1):533-542. doi: 10.1080/07853890.2023.2175031. Ann Med. 2023. PMID: 36745515 Free PMC article.
-
The management of diabetic ketoacidosis at a rural regional hospital in KwaZulu-Natal.Afr J Prim Health Care Fam Med. 2018 Mar 22;10(1):e1-e6. doi: 10.4102/phcfm.v10i1.1612. Afr J Prim Health Care Fam Med. 2018. PMID: 29781681 Free PMC article.
-
Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes.Acta Diabetol. 2020 Oct;57(10):1245-1253. doi: 10.1007/s00592-020-01538-0. Epub 2020 Jun 2. Acta Diabetol. 2020. PMID: 32488499 Free PMC article.
-
Comparing patient characteristics and outcomes in type 1 versus type 2 diabetes with diabetic ketoacidosis: a review and a propensity-matched nationwide analysis.J Investig Med. 2021 Aug;69(6):1196-1200. doi: 10.1136/jim-2021-001901. Epub 2021 May 10. J Investig Med. 2021. PMID: 33972382 Review.
-
An Approach to Diabetic Ketoacidosis in an Emergency Setting.Rev Recent Clin Trials. 2020;15(4):278-288. doi: 10.2174/1574887115666200709172402. Rev Recent Clin Trials. 2020. PMID: 32646361 Review.
References
-
- Diabetes UK . Number of people with diabetes reaches 4.8 million. Diabetes UK, 2019. www.diabetes.org.uk/about_us/news/diabetes-prevalence-2019
-
- NHS Digital . National Diabetes Inpatient Audit (NaDIA) - 2017. NHS, 2018. https://digital.nhs.uk/data-and-information/publications/statistical/nat...
-
- Joint British Diabetes Societies for Inpatient Care . The management of diabetic ketoacidosis in adults. JBDS-IP, 2021. https://abcd.care/sites/abcd.care/files/site_uploads/JBDS_Guidelines_Cur...
-
- Musso G, Saba F, Cassader M, Gambino R. Diabetic ketoacidosis with SGLT2 inhibitors. BMJ 2020;371:m4147. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical